HAMP and diabetes mellitus: Another randomized study investigated the effect of dapagliflozin on the levels of Ht and hepcidin (a suppressive hormone for hemopoiesis which increases in pre-inflammatory conditions such as DM or HF) in 52 patients with type 2 DM (30).